You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Spirea raises £2.4m to develop antibody drug conjugates in cancer

Spirea – a spin-out from Cambridge University – has announced that it has secured funding of £2.4m with investments from several high-profile UK and US investors.